T0	Citation 4065 4067	10
T1	Citation 4273 4275	10
T2	MultiCitation 4475 4477	10
T3	Citation 5036 5038	10
T4	MultiCitation 5198 5200	10
T5	Citation 7435 7437	10
T6	MultiCitation 7560 7562	10
T7	Citation 7618 7620	10
T8	Citation 8350 8352	10
T9	Span 3890 4069	By contrast, Hrecka and colleagues identified SAMHD1 from HEK 293T cells expressing tagged Vpx in a proteomic screen using multidimensional protein identification technology [10].
R1	Context Target:T0 Context:T9	
T10	Span 4070 4277	They demonstrated that Vpx relieves the inhibition of HIV-1 infection in monocyte-derived macrophages by mediating proteasome-dependent degradation of SAMHD1 through the CUL4A/DCAF1 E3 ubiquitin ligase [10].
R2	Context Target:T1 Context:T10	
T11	Span 4278 4479	Both studies confirmed that Vpx interacts with SAMHD1 and induces proteasomal degradation of SAMHD1 in THP-1 cells or macrophages, which can be restored by treatment with a proteasome inhibitor [9,10].
R3	Context Target:T2 Context:T11	
T12	Span 4906 5074	Further analysis revealed that SAMHD1 blocks HIV-1 reverse transcription, as silencing SAMHD1 in THP-1 cells [9] and macrophages [10] increases the levels of viral DNA.
R4	Context Target:T3 Context:T12	
T13	Span 5075 5213	Together, these studies suggested that SAMHD1 is the myeloid-cell specific HIV-1 restriction factor counteracted by Vpx [9,10] (Figure 1).
R5	Context Target:T4 Context:T13	
T14	Span 7345 7439	It might be possible that SAMHD1 acts in concert with another myeloid-specific co-factor [10].
R6	Context Target:T5 Context:T14	
T15	Span 7440 7622	It appears that only Vpx from the SIVsm/HIV-2 lineage counteracts SAMHD1-mediated HIV-1 restriction in myeloid cells [9,10], while HIV-1 Vpr does not interact or degrade SAMHD1 [10].
R7	Context Target:T6 Context:T15	
R8	Context Target:T7 Context:T15	
T16	Span 8241 8353	SAMHD1-mediated HIV-1 restriction has so far been analyzed only in monocyte-derived DCs [9] and macrophages [10]
R9	Context Target:T8 Context:T16	
